Sotera Health Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US83601L1026
USD
16.56
-0.37 (-2.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
294.34
254.52
290.20
285.47
276.59
248.18
310.24
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
294.34
254.52
290.20
285.47
276.59
248.18
310.24
Raw Material Cost
137.02
134.42
141.22
142.95
139.22
136.79
145.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
40.74
40.28
66.15
36.91
31.84
43.04
26.32
Selling and Distribution Expenses
52.43
48.69
47.03
51.42
52.16
51.82
39.74
Other Expenses
-4.07
-4.03
-6.62
-3.69
-3.18
-4.30
-2.63
Total Expenditure (Excl Depreciation)
189.45
183.10
188.25
194.37
191.38
188.61
185.60
Operating Profit (PBDIT) excl Other Income
104.9
71.39999999999999
102
91.1
85.19999999999999
59.6
124.60000000000001
Other Income
0.54
-1.80
26.07
1.27
-5.68
2.71
-15.71
Operating Profit (PBDIT)
141.01
110.99
167.73
135.56
120.00
103.35
150.38
Interest
40.74
40.28
66.15
36.91
31.84
43.04
26.32
Exceptional Items
-45.80
-44.15
-16.91
-12.71
-32.55
-8.23
-16.94
Gross Profit (PBDT)
157.32
120.11
148.98
142.52
137.37
111.38
164.38
Depreciation
35.58
41.38
39.71
43.19
40.47
41.07
41.45
Profit Before Tax
18.90
-14.82
44.96
42.75
15.14
11.01
65.67
Tax
10.94
-1.56
32.64
25.76
6.39
4.69
26.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
7.96
-13.26
12.32
16.99
8.75
6.30
38.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
7.96
-13.26
12.32
16.99
8.75
6.30
38.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
7.96
-13.26
12.32
16.99
8.75
6.30
38.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
511.28
414.09
404.91
470.16
422.76
429.39
443.73
Earnings per share (EPS)
0.03
-0.05
0.04
0.06
0.03
0.02
0.14
Diluted Earnings per share
0.03
-0.05
0.04
0.06
0.03
0.02
0.14
Operating Profit Margin (Excl OI)
35.64%
28.06%
35.13%
31.91%
30.81%
24.0%
40.17%
Gross Profit Margin
18.51%
10.43%
29.18%
30.11%
20.1%
20.99%
34.53%
PAT Margin
2.7%
-5.21%
4.24%
5.95%
3.16%
2.54%
12.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 15.64% vs -12.30% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 160.15% vs -208.13% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 24.56% vs -20.40% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.99% vs -39.12% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Sotera Health Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
294.34
321.39
-27.05
-8.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
294.34
321.39
-27.05
-8.42%
Raw Material Cost
137.02
140.93
-3.91
-2.77%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
40.74
4.07
36.67
900.98%
Selling and Distribution Expenses
52.43
109.75
-57.32
-52.23%
Other Expenses
-4.07
1.15
-5.22
-453.91%
Total Expenditure (Excl Depreciation)
189.45
266.26
-76.81
-28.85%
Operating Profit (PBDIT) excl Other Income
104.90
55.14
49.76
90.24%
Other Income
0.54
0.00
0.54
Operating Profit (PBDIT)
141.01
83.90
57.11
68.07%
Interest
40.74
4.07
36.67
900.98%
Exceptional Items
-45.80
-5.90
-39.90
-676.27%
Gross Profit (PBDT)
157.32
180.47
-23.15
-12.83%
Depreciation
35.58
28.76
6.82
23.71%
Profit Before Tax
18.90
45.17
-26.27
-58.16%
Tax
10.94
11.14
-0.20
-1.80%
Provisions and contingencies
0
0
0.00
Profit After Tax
7.96
34.03
-26.07
-76.61%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
7.96
34.03
-26.07
-76.61%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
7.96
34.03
-26.07
-76.61%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
511.28
882.30
-371.02
-42.05%
Earnings per share (EPS)
0.03
0.70
-0.67
-95.71%
Diluted Earnings per share
0.03
0.70
-0.67
-95.71%
Operating Profit Margin (Excl OI)
35.64%
17.16%
0.00
18.48%
Gross Profit Margin
18.51%
23.00%
0.00
-4.49%
PAT Margin
2.70%
10.59%
0.00
-7.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 29.43 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.64% vs -12.30% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 6.40% vs 8.34% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 160.15% vs -208.13% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.05% vs -62.82% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.05 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 24.56% vs -20.40% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.77% vs 1.45% in Jun 2024

Quarterly - Interest
Interest 4.07 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.99% vs -39.12% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 27.99% vs 19.10% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.64%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024